Literature DB >> 26823565

Effect of Attenuation Correction on Regional Quantification Between PET/MR and PET/CT: A Multicenter Study Using a 3-Dimensional Brain Phantom.

Jarmo Teuho1, Jarkko Johansson2, Jani Linden2, Adam Espe Hansen3, Søren Holm3, Sune H Keller3, Gaspar Delso4, Patrick Veit-Haibach4, Keiichi Magota5, Virva Saunavaara2, Tuula Tolvanen2, Mika Teräs6, Hidehiro Iida7.   

Abstract

UNLABELLED: A spatial bias in brain PET/MR exists compared with PET/CT, because of MR-based attenuation correction. We performed an evaluation among 4 institutions, 3 PET/MR systems, and 4 PET/CT systems using an anthropomorphic brain phantom, hypothesizing that the spatial bias would be minimized with CT-based attenuation correction (CTAC).
METHODS: The evaluation protocol was similar to the quantification of changes in neurologic PET studies. Regional analysis was conducted on 8 anatomic volumes of interest (VOIs) in gray matter on count-normalized, resolution-matched, coregistered data. On PET/MR systems, CTAC was applied as the reference method for attenuation correction.
RESULTS: With CTAC, visual and quantitative differences between PET/MR and PET/CT systems were minimized. Intersystem variation between institutions was +3.42% to -3.29% in all VOIs for PET/CT and +2.15% to -4.50% in all VOIs for PET/MR. PET/MR systems differed by +2.34% to -2.21%, +2.04% to -2.08%, and -1.77% to -5.37% when compared with a PET/CT system at each institution, and these differences were not significant (P ≥ 0.05).
CONCLUSION: Visual and quantitative differences between PET/MR and PET/CT systems can be minimized by an accurate and standardized method of attenuation correction. If a method similar to CTAC can be implemented for brain PET/MRI, there is no reason why PET/MR should not perform as well as PET/CT.
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  PET/CT; PET/MR; attenuation correction; phantom; quantification

Mesh:

Year:  2016        PMID: 26823565     DOI: 10.2967/jnumed.115.166165

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

Review 1.  Using PET for therapy monitoring in oncological clinical trials: challenges ahead.

Authors:  C M Deroose; S Stroobants; Y Liu; L K Shankar; P Bourguet
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-27       Impact factor: 9.236

2.  Quantitative hemodynamic PET imaging using image-derived arterial input function and a PET/MR hybrid scanner.

Authors:  Yi Su; Andrei G Vlassenko; Lars E Couture; Tammie Ls Benzinger; Abraham Z Snyder; Colin P Derdeyn; Marcus E Raichle
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

3.  Reproducibility and repeatability of same-day two sequential FDG PET/MR and PET/CT.

Authors:  David Groshar; Hanna Bernstine; Natalia Goldberg; Meital Nidam; Dan Stein; Ifat Abadi-Korek; Liran Domachevsky
Journal:  Cancer Imaging       Date:  2017-04-05       Impact factor: 3.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.